IMI LAUNCHES NEW CALL FOR PROPOSALS

IMI has launched its 5th Call for proposals under IMI 2, with topics on Alzheimer's disease,diabetic kidney disease, and patient engagement in research and drug development.

Submission deadline: 13 October 2015

Call description

Topics
  • Topic 1: Patient perspective elicitation on benefits and risks of medicinal products, from development through the entire life cycle, to inform the decision-making process by regulators and health technology assessment bodies      
  • Topic 2: Diabetic kidney disease biomarkers (DKD-BM)
  • Topic 3: Inflammation and AD: modulating microglia function – focussing on TREM2 and CD33
  • Topic 4: Understanding the role of amyloid imaging biomarkers in the current and future diagnosis and management of patients across the spectrum of cognitive impairment (from pre-dementia to dementia)   
  • Topic 5: Evolving models of patient engagement and access for earlier identification of Alzheimer’s disease: phased expansion study           
  • Topic 6: From ApoE biology to validated Alzheimer’s disease targets     

 

Richard Buxbaum - Scotland Europa - NCP Services